4-821-725
| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| 5g | ￥ ƴǹŶǹǹ | > 1 | > 1 | -- | -- | -- | -- | ￥ ƴǹŶǹǹ | - + |
| 1g | ￥ ƇƿŶǹǹ | > 1 | > 1 | -- | -- | -- | 1 | ￥ ƇƿŶǹǹ | - + |
| 25g | ￥ ŜƿŶǹǹ | > 1 | > 1 | 1 | 1 | 1 | -- | ￥ ŜƿŶǹǹ | - + |
| 1g | ￥ ÞōƩŶǹǹ | 4 | > 1 | -- | 1 | 2 | 1 | ￥ ÞōƩŶǹǹ | - + |
| 5g | ￥ ǪÞƇŶǹǹ | -- | > 1 | -- | -- | 2 | 1 | ￥ ǪÞƇŶǹǹ | - + |
| 25g | ￥ ÞōƩƿŶǹǹ | -- | 8 | -- | -- | -- | -- | ￥ ÞōƩƿŶǹǹ | - + |
5.5
[1]. Atsushi Kambayashi, et al. Predicting the oral pharmacokinetic profiles of multiple-unit (pellet) dosage forms using a modeling and simulation approach coupled with biorelevant dissolution testing: case example diclofenac sodium. Eur J Pharm Biopharm. 214 Jul;87(2):26-4.
[2]. Hywel D Williams, et al. Lipid-based formulations solidified via adsorption onto the mesoporous carrier Neusilin? US2: effect of drug type and formulation composition on in vitro pharmaceutical performance. J Pharm Sci. 214 Jun;1(6):174-46.
[]. Hywel D Williams, et al. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 4: proposing a new lipid formulation performance classification system. J Pharm Sci. 214 Aug;1(8):2441-55.
[4]. Joseph P O Shea, et al. Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: In vitro, in vivo and in silico assessments. Eur J Pharm Biopharm. 215 Oct:96:27-16.
[5]. Karen Kleberg, et al. Sensing of triacylglycerol in the gut: different mechanisms for fatty acids and 2-monoacylglycerol. J Physiol. 215 Apr 15;59(8):297-19.
H2+H12+H2-H4
P261-P264-P27-P271-P28-P2+P52-P4+P4-P-P62-P45-P51
GHS8
281
11677 现货
115521 现货
￥ ƇōŶǹǹ -25mg
1225822 现货
￥ ƴǹŶǹǹ -1mg
1278679 现货
￥ ǪƇŶǹǹ -25mg
1574 现货
￥ ŜǹǹŶǹǹ -1mg
15741 现货
￥ ƁƿōŶǹǹ -1mg
121772 货期咨询
176126 货期咨询
￥ ōƿŶǹǹ -25mg
18222 货期咨询
182221 货期咨询
沪ICP备1719645号
